Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/10387
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKenward, Michael G.-
dc.contributor.authorMOLENBERGHS, Geert-
dc.date.accessioned2010-02-03T19:47:27Z-
dc.date.available2010-02-03T19:47:27Z-
dc.date.issued2009-
dc.identifier.citationJOURNAL OF BIOPHARMACEUTICAL STATISTICS, 19 (5). p. 872-888-
dc.identifier.issn1054-3406-
dc.identifier.urihttp://hdl.handle.net/1942/10387-
dc.description.abstractIn spite of widespread criticism and notwithstanding the availability of flexible, broadly valid, and conveniently implemented methods like direct-likelihood and direct-Bayesian analyses, last observation carried forward (LOCF), baseline observation carried forward (BOCF), and complete case analysis remain popular for handling incomplete clinical trial data. To the well-known criticisms toward LOCF and BOCF, namely, that they can be either conservative or liberal depending on the context, that they can violate the intention-to-treat principle, and so on, we add that, with the exception of certain degenerate and unrealistic special cases, these methods are incompatible with the sensible requirement that the mechanism governing dropout be independent of future, unobserved measurements, given covariates, past observed measurements, and the current possibly missing measurement.-
dc.description.sponsorshipThe authors gratefully acknowledge support from IAP research Network P6/03 of the Belgian Government (Belgian Science Policy).-
dc.language.isoen-
dc.publisherTAYLOR & FRANCIS INC-
dc.rightsCopyright © Taylor & Francis Group, LLC-
dc.subject.otherbaseline observation carried forward; BOCF; complete case analysis; direct likelihood; LOCF; missing at random; missing not at random; pattern-mixture model; selection model-
dc.subject.otherBaseline observation carried forward; BOCF; Complete case analysis; Direct likelihood; LOCF; Missing at random; Missing not at random; Pattern-mixture model; Selection model-
dc.titleLast observation carried forward: A crystal ball?-
dc.typeJournal Contribution-
dc.identifier.epage888-
dc.identifier.issue5-
dc.identifier.spage872-
dc.identifier.volume19-
local.format.pages17-
local.bibliographicCitation.jcatA1-
dc.description.notes[Molenberghs, Geert] Univ Hasselt, I BioStat, B-3590 Diepenbeek, Belgium. [Molenberghs, Geert] Katholieke Univ Leuven, I BioStat, Louvain, Belgium. [Kenward, Michael G.] London Sch Hyg & Trop Med, Med Stat Unit, London WC1, England. geert.molenberghs@uhasselt.be-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.bibliographicCitation.oldjcatA1-
dc.identifier.doi10.1080/10543400903105406-
dc.identifier.isi000273623200009-
item.accessRightsRestricted Access-
item.contributorKenward, Michael G.-
item.contributorMOLENBERGHS, Geert-
item.fullcitationKenward, Michael G. & MOLENBERGHS, Geert (2009) Last observation carried forward: A crystal ball?. In: JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 19 (5). p. 872-888.-
item.fulltextWith Fulltext-
item.validationecoom 2011-
crisitem.journal.issn1054-3406-
crisitem.journal.eissn1520-5711-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
kenward2009.pdf
  Restricted Access
Published version137.31 kBAdobe PDFView/Open    Request a copy
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.